Your Feed

Filter by
See content from
Back to the latest
Thumbnail for Optimizing BTK Inhibitor Treatment in CLL: Dose Reduction Impact | Kerry Rogers, MD | ASH 2023
Playlist: ASH 2023

Optimizing BTK Inhibitor Treatment in CLL: Dose Reduction Impact | Kerry Rogers, MD | ASH 2023

Video details & playlist
Thumbnail for Second Generation CLL Treatment: Zanubrutinib + Sonrotoclax | Constantine Tam, MD, MBBS | ASH 2023
Playlist: ASH 2023

Second Generation CLL Treatment: Zanubrutinib + Sonrotoclax | Constantine Tam, MD, MBBS | ASH 2023

Video details & playlist
Thumbnail for Optimizing CLL Treatment: BTK Resistance and Dual Therapy | Kerry Rogers, MD | ASH 2023
Playlist: ASH 2023

Optimizing CLL Treatment: BTK Resistance and Dual Therapy | Kerry Rogers, MD | ASH 2023

Video details & playlist
Thumbnail for ALPINE Trial: Zanubrutinib vs Ibrutinib in Treating CLL | Constantine Tam, MD, MBBS | ASH 2023
Playlist: ASH 2023

ALPINE Trial: Zanubrutinib vs Ibrutinib in Treating CLL | Constantine Tam, MD, MBBS | ASH 2023

Video details & playlist
Thumbnail for Costs of Venetoclax-Obinutuzumab vs. BTKi in CLL | Scott Huntington, MD, MPH, MSc | ASH 2023
Playlist: ASH 2023

Costs of Venetoclax-Obinutuzumab vs. BTKi in CLL | Scott Huntington, MD, MPH, MSc | ASH 2023

Video details & playlist